To include your compound in the COVID-19 Resource Center, submit it here.

Avandia rosiglitazone endocrine data

Last year, EMA suspended Avandia based on cardiovascular safety concerns. FDA also significantly restricted Avandia in the U.S., restricting it to only patients who had failed other drugs and are medically unable to take Actos pioglitazone (see BioCentury, Sept. 27,

Read the full 402 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers